Alerts
PDF
Other content recommended for you
- Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK
- Postmortem brain donation and organ transplantation in schizophrenia: what about patient consent?
- Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials
- Effects of the combination of second-generation antipsychotics on serum concentrations of aripiprazole and dehydroaripiprazole in Chinese patients with schizophrenia
- Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study
- Comparison of prediction methods for treatment continuation of antipsychotics in children and adolescents with schizophrenia
- Dramatic weight loss associated with commencing clozapine
- Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia
- Patients’ and oncologists’ perceptions towards the discussion on high-cost innovative cancer therapies: findings from a qualitative study
- Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study